An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Precision BioSciences to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Precision BioSciences, Inc. (NASDAQ: DTIL) announced its participation in the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. A fireside chat is scheduled for September 13, 2022, at 4:30 PM ET, located at the Lotte New York Palace Hotel. The session will be available via a recording on Precision's website the next day, with an archived replay for 30 days. Precision BioSciences focuses on gene editing using its ARCUS® platform to develop CAR T and gene editing therapies for genetic and infectious diseases.
Positive
None.
Negative
None.
DURHAM, N.C.--(BUSINESS WIRE)--
Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that the Company will participate in the H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022.
Details for the in-person fireside chat are as follows:
Date: Tuesday, September 13, 2022 Time: 4:30 PM ET Location: Lotte New York Palace Hotel
The fireside chat will be available via a recorded webcast accessible on Precision’s website in the Investors section under Events & Presentations on September 14, 2022: https://investor.precisionbiosciences.com/events-and-presentations. An archived replay will be available for approximately 30 days following the event.
About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly precise and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple ex vivo “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene editing candidates designed to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.
What is the H.C. Wainwright 24th Annual Global Investment Conference?
It is a conference where companies like Precision BioSciences participate to discuss their business and investment opportunities, scheduled for September 12-14, 2022.
When will Precision BioSciences' fireside chat take place during the conference?
The fireside chat is scheduled for September 13, 2022, at 4:30 PM ET.
Where is the fireside chat being held?
The fireside chat will take place at the Lotte New York Palace Hotel.
How can I access the recorded fireside chat?
The recorded fireside chat will be available on Precision's website in the Investors section on September 14, 2022.
What does Precision BioSciences do?
Precision BioSciences is a clinical stage biotechnology company focused on developing gene editing therapies using its ARCUS® platform.
